Anzeige
Mehr »
Donnerstag, 23.04.2026 - Börsentäglich über 12.000 News
Diese Aktie zündet die nächste Explorationsstufe - und der Markt beginnt aufzuwachen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

NASDAQ Biotech 

WKN:  ISIN:  
Markt oder Branche auswählen:

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:  Alle DE EN
LeserMedien
00:34Medpace (MEDP) Q1 Earnings and Revenues Beat Estimates2
00:29Medpace Holdings, Inc. Bottom Line Rises In Q11
MiMedpace falls despite Q1 beats; 2026 guidance ranges include consensus1
MiFDA Nod for Merck HIV Drug Brings Competition to a Gilead Sciences Antiretroviral3
MiVanda Pharmaceuticals adds Charles Duncan to board1
MiRegeneron Pharmaceuticals, Inc.: Dupixent (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)3
MiSanofi: Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria238Sanofi and Regeneron's Dupixent approved in the US as the first biologic medicine for young children with uncontrolled chronic spontaneous urticaria Approval for children aged two to 11 years with...
► Artikel lesen
MiVanda Pharmaceuticals erweitert Verwaltungsrat um Charles Duncan2
MiNeurocrine meldet anhaltende Glukokortikoid-Reduktion in CAH-Studie6
MiAltimmune launches proposed public offering to fund late-stage trial3
MiDefinium expects three trial readouts for depression, anxiety drug2
MiAltimmune, Inc: Altimmune Announces Proposed Underwritten Public Offering of Securities3
MiVanda Pharmaceuticals Inc. - 8-K, Current Report-
MiNeurocrine reports sustained glucocorticoid reductions in CAH study1
MiMedpace GAAP EPS of $4.28 beats by $0.40, revenue of $706.6M beats by $8.97M3
MiLifecore Biomedical, Inc.: Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)1
MiEQS-News: ABIVAX: Abivax to Present Data on Obefazimod at Digestive Disease Week221EQS-News: ABIVAX / Key word(s): Conference Abivax to Present Data on Obefazimod at Digestive Disease Week 22.04.2026 / 22:05 CET/CEST The issuer is solely responsible...
► Artikel lesen
MiAlpha Teknova, Inc.: Teknova to Report First Quarter 2026 Financial Results on May 6, 20261
MiRaymond James bestätigt "Outperform"-Rating für Regeneron mit Kursziel von 910 US-Dollar3
MiMaze Therapeutics, Inc. - 8-K, Current Report-
Weiter >>